Nixodine contains 6-methylnicotine, a chemical related to nicotine that can produce nicotine-like effects. This guide explains the ingredient, the strength warning and the risks in plain language.

Strength warning

It may feel stronger than you expect. Do not assume it matches a nicotine product’s strength—even when both labels show the same percentage.

A percentage on a label is not a promise of an equivalent experience. It matters what the percentage measures, how the formula is prepared and how much the device delivers. Check the manufacturer’s current ingredient information rather than treating “5% Nixodine” as interchangeable with “5% nicotine.”

What is Nixodine?

Nixodine is a branded formulation. Its supplier identifies the active ingredient as 6-methylnicotine. Scientists call this a nicotine analogue: a related chemical with a different structure. It can act on some of the same receptors in the body that respond to nicotine.

Some products use the name Nixodine-S. A prepared, diluted formula is different from the pure active chemical. Findings about one should not automatically be applied to the other—or to every finished vape.

Does “nicotine-free” mean it has no active ingredient?

No. A product can be described as containing no conventional nicotine while still containing a nicotine analogue. That wording does not mean harmless or free of habit-forming effects.

What are the risks?

It may be habit-forming. Its long-term health risks are still being studied. Stop using it if you feel unwell.

There is not enough evidence to promise that a finished Nixodine vape has the same long-term risks as a nicotine vape. A stronger effect is not a sign that a product is safer. Do not keep using a product to test your tolerance when it makes you feel unwell.

Keep devices and liquids away from children and pets. These products are for adults 21+ and are not intended for people who do not already use tobacco or nicotine products. They are not smoking-cessation treatments.

What does the research actually say?

A 2026 study compared a specific diluted Nixodine-S formulation with nicotine. It found similar activity at two tested receptor types, lower potency at another, and lower cell toxicity under its laboratory conditions. These results describe that formulation and those tests; they do not establish overall safety for people using finished vapes over time.

The research also examined the pure active compound. Greater acute toxicity in animal testing informed the diluted formulation. This is why “pure ingredient,” “prepared formula” and “finished product” should not be treated as the same thing. The study was industry funded and disclosed author financial interests.

Questions to ask about a label

• What exact ingredient does this product contain?
• What does the listed percentage measure?
• Is there a current batch report for the finished product?
• What warnings and operating instructions does the manufacturer provide?

If those answers are unclear, ask the manufacturer or retailer for clarification. A familiar-looking device or matching percentage does not establish matching strength.

Sources

• Bonguard Naturals: ingredient information and warnings
• 2026 Nixodine-S toxicology and receptor study

Educational information updated October 4, 2026. This guide does not establish the safety or strength of an individual product.